Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors

Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors

Background: Immune checkpoint inhibitors (ICIs) have become the mainstay treatment of metastatic kidney cancer, demonstrating enhanced outcomes and durable responses in select patient subgroups. However, identifying reliable prognostic biomarkers for treatment outcomes remains challenging. Objective...

Full description

Bibliographic Details
Main Authors: Ahmet Yildirim, Mengting Wei, Yuan Liu, Bassel Nazha, Jacqueline T. Brown, Bradley C. Carthon, Yujin Choi, Lauren Suh, Rohit V. Goswamy, Greta R. McClintock, Caitlin Hartman, Sarah Caulfield, Jordan Ciuro, Jamie M. Goldman, Wayne B. Harris, Omer Kucuk, Viraj A. Master, Mehmet A. Bilen
Format: Article
Language:English
Published: SAGE Publishing 2025-02-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251316243

Internet

https://doi.org/10.1177/17588359251316243

Similar Items